Idiopathic Hypersomnia (IH) | Norton Healthcare

Indication: Idiopathic Hypersomnia (IH)

A Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Oral BTD-001 in Adults with Idiopathic Hypersomnia

Adult patients

Drug Study

Principal Investigator: David Winslow, M.D.
Norton Pulmonary Specialists, Norton Sleep Center

Sponsor: Balance Therapeutics, Inc

Learn more at ClinicalTrials.gov

Email for more information: NCRG@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.